| Large deletions induced by Cas9 cleavage F Adikusuma, S Piltz, MA Corbett, M Turvey, SR McColl, KJ Helbig, ... Nature 560 (7717), E8-E9, 2018 | 335 | 2018 |
| Viperin is an important host restriction factor in control of Zika virus infection KH Van der Hoek, NS Eyre, B Shue, O Khantisitthiporn, K Glab-Ampi, ... Scientific reports 7 (1), 4475, 2017 | 120 | 2017 |
| Targeted deletion of an entire chromosome using CRISPR/Cas9 F Adikusuma, N Williams, F Grutzner, J Hughes, P Thomas Molecular Therapy 25 (8), 1736-1738, 2017 | 99 | 2017 |
| Optimized nickase- and nuclease-based prime editing in human and mouse cells F Adikusuma, C Lushington, J Arudkumar, GI Godahewa, YCJ Chey, ... Nucleic Acids Research 49 (18), 10785–10795, 2021 | 61 | 2021 |
| A Y-chromosome shredding gene drive for controlling pest vertebrate populations TAA Prowse*, F Adikusuma*, P Cassey, P Thomas, JV Ross Elife 8, e41873, 2019 | 50 | 2019 |
| Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression F Adikusuma, C Pfitzner, PQ Thomas PLoS One 12 (12), e0187236, 2017 | 48 | 2017 |
| Functional equivalence of the SOX2 and SOX3 transcription factors in the developing mouse brain and testes F Adikusuma, D Pederick, D McAninch, J Hughes, P Thomas Genetics 206 (3), 1495-1503, 2017 | 35 | 2017 |
| Progress toward zygotic and germline gene drives in mice C Pfitzner, MA White, SG Piltz, M Scherer, F Adikusuma, JN Hughes, ... The CRISPR Journal 3 (5), 388-397, 2020 | 30 | 2020 |
| Antisense oligonucleotide therapy for KCNT1 encephalopathy LE Burbano, M Li, N Jancovski, P Jafar-Nejad, K Richards, A Sedo, ... JCI insight 7 (23), 2022 | 26 | 2022 |
| CRISPR applications for Duchenne muscular dystrophy: from animal models to potential therapies YCJ Chey, J Arudkumar, A Aartsma‐Rus, F Adikusuma*, PQ Thomas* WIREs Mechanisms of Disease 15 (1), e1580, 2023 | 10 | 2023 |
| Expanding the RNA-Guided Endonuclease Toolkit for Mouse Genome Editing L Robertson, D Pederick, S Piltz, M White, A Nieto, M Ahladas, ... The CRISPR Journal 1 (6), 431-439, 2018 | 8 | 2018 |
| The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development E Thomson, R Dawson, CH H’ng, F Adikusuma, S Piltz, PQ Thomas PloS one 16 (11), e0258538, 2021 | 2 | 2021 |
| Megabase-scale Transgene De-Duplication to Generate a Functional Single-Copy Full-Length Humanized DMD Mouse Model YCJ Chey, MA Corbett, J Arudkumar, S Piltz, PQ Thomas, F Adikusuma bioRxiv, 2024.03. 25.586713, 2024 | | 2024 |
| Agent for treating or preventing a dominantly-inherited disease PQ THOMAS, F ADIKUSUMA, AB GEIGER | | 2024 |
| Enhancing gRNA Transcript levels by Reducing the Scaffold Poly-T Tract for Optimal SpCas9-and SaCas9-mediated Gene Editing YCJ Chey, L Gierus, C Lushington, JC Arudkumar, A Geiger, LG Staker, ... bioRxiv, 2024.07. 19.604224, 2024 | | 2024 |
| Genetically edited placental organoids cast new light on the role of ACE2 in placental development AL Arthurs, B Dietrich, M Knoefler, CJ Lushington, PQ Thomas, ... bioRxiv, 2024.05. 09.592870, 2024 | | 2024 |
| Safe development of CRISPR gene drives for invasive rodent population suppression C Pfitzner, T Prowse, F Adikusuma, S Piltz, P Cassey, J Ross, P Thomas TRANSGENIC RESEARCH 29 (4), 467-468, 2020 | | 2020 |
| Development and Applications of CRISPR/Cas9 Genome Editing Technology F Adikusuma | | 2017 |
| Rapid generation of mutant mice using CRISPR-mediated genome editing (tips and tricks) S Piltz, F Adikusuma, J Hughes, P Thomas TRANSGENIC RESEARCH 23 (5), 867-867, 2014 | | 2014 |
| CHARACTERIZATION OF AN INDUCIBLE TRANSGENIC MOUSE MODEL FOR FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME (FXTAS) F Adikusuma Diponegoro University, 2011 | | 2011 |
James HughesAdelaide UniversityVerified email at adelaide.edu.au
